K562-Fluc-Puro/HuCD19-Puro

• Frozen / Standard (CL190) $ 3,000

Species: Human

Cell Type: Chronic Myelogenous Leukemia

Transgenes: Firefly luciferase (Fluc; Luc2)

Human CD19 (HuCD19)

Selection Gene: Puromycin resistance (Puro)

Description: 

The K562-Fluc-Puro/HuCD19-Puro cell line stably expresses firefly luciferase and human CD19. The cells are designed for in vitro and in vivo studies of CD19. Parental K562-Fluc-Puro cells can be used as a negative control.

Imanis K562-Fluc-Puro cells (Imanis #CL171) cells were transduced with a human CD19-encoding lentivirus. A high HuCD19 expressing population was generated by selection using a methylcellulose based semi-solid medium. 

This cell line has been tested for mycoplasma contamination and is certified mycoplasma free.

The parental K562 cell line was licensed and purchased directly from ATCC*.

Replication Competent Lentivirus (RCL) Test (including a test report) is available for this cell line at an added cost. Contact us to learn more.

*The ATCC trademark and trade name and any and all ATCC catalog numbers are trademarks of the American Type Culture Collection.

Characterization: 

Morphology

Phase cell photo taken at 200x magnification

Luciferase Expression

The indicated number of cells were placed in wells of a 96-well plate. After the addition of 15 mg/mL d-luciferin, bioluminescence was immediately read using a microplate reader.

CD19 Expression

K562-Fluc-Puro/HuCD19-Puro cells were stained with an anti-HuCD19 (blue) or isotype control (grey) antibody and analyzed by flow cytometry.

Surface Receptor Profiling

K562-Fluc-Puro/HuCD19-Puro cells were stained with an anti-HuBCMA (A), anti-CD20 (B), anti-HuGPRC5D (C), or anti-HuCD38 (D) antibody and analyzed by flow cytometry.

Growth Conditions

Complete Growth Medium: Iscove’s Modified Dulbecco’s Medium (IMDM) supplemented with 15% fetal bovine serum (FBS) and 1% Penicillin/Streptomycin. 

For long-term maintenance (more than two to three weeks) addition of 6 µg/mL of puromycin to the media is recommended to maintain high Fluc and HuCD19 expression. 

These cells should be grown in the indicated medium and subcultured as needed to maintain a density between 5 x 105 and 2 x 106 cells/mL. The cells can be passaged by dilution in fresh medium, with occasional passaging using centrifugation to limit the amount of debris in cultures.  

Usage Information

These cells are suitable for in vitro and in vivo experimentation. The Fluc transgene facilitates in vivo noninvasive bioluminescent imaging of implanted cells and quantitation of cells in vitro.

These cells were generated via lentiviral vector transduction. The lentiviral vectors used for transduction were self-inactivating (SIN) vectors in which the viral enhancer and promoter have been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without cis-acting effects of the LTR1. Nevertheless, all work with these cells should be performed under biosafety-level 2 (BSL2) conditions by trained personnel. Institutional requirements may permit handling of these cells under BSL1 conditions if certain criteria are met.

1. Miyoshi, H et al. (1998). Development of a self-inactivating lentivirus vector. Journal of Virology 72: 8150-8157.